| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |